Delayed methimazole-induced agranulocytosis in a 6-year old patient with Graves ’ disease
Agranulocytosis is regarded as a rare side effect of methimazole (MMI) therapy that occurs in a dose dependent manner and that usually develops within the first 3 –6 months of treatment. Although delayed develo...
Source: International Journal of Pediatric Endocrinology - Category: Endocrinology Authors: Vidya Puthenpura, Kinjal Desai, Andrew Bauer and Ian Marshall Source Type: research
More News: Endocrinology | Pediatrics